Complications after proton radiotherapy in children, focusing on severe late complications. A complete Swedish cohort 2008–2019

References

• Jemal A, Siegel R, Xu J, et al. Cancer statistics, 2010. CA Cancer J Clin. 2010;60(5):277–300. doi: 10.3322/caac.20073.
   PubMed Web of Science ®Google Scholar
• Howlader N, Noone AM, Krapcho M, et al. SEER cancer statistics review, 1975-2010. Bethesda: National Cancer Institute; 2013.
   Google Scholar
• Oeffinger KC, Mertens AC, Sklar CA, et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med. 2006;355(15):1572–1582. doi: 10.1056/NEJMsa060185.
   PubMed Web of Science ®Google Scholar
• Geenen MM, Cardous-Ubbink MC, Kremer LCM, et al. Medical assessment of adverse health outcomes in long-term survivors of childhood cancer. JAMA. 2007;297(24):2705–2715. doi: 10.1001/jama.297.24.2705.
   PubMed Web of Science ®Google Scholar
• Kortelainen S, Harju T, Juntti H, et al. Late effects and survival of children with malignant solid tumours in Northern Finland: a single-centre cohort study. Eur J Pediatr. 2022;181(6):2263–2272. doi: 10.1007/s00431-022-04399-7.
   PubMed Web of Science ®Google Scholar
• Suh E, Stratton KL, Leisenring WM, et al. Late mortality and chronic health conditions in long-term survivors of early-adolescents and young adult cancers: a retrospective cohort analysis from the childhood cancer survivor study. Lancet Oncol. 2020;21(3):421–435. doi: 10.1016/S1470-2045(19)30800-9.
   PubMed Web of Science ®Google Scholar
• Armstrong GT, Liu Q, Yasui Y, et al. Late mortality among 5-year survivors of childhood cancer: a summary from the childhood cancer survivor study. J Clin Oncol. 2009;27(14):2328–2338. doi: 10.1200/JCO.2008.21.1425.
   PubMed Web of Science ®Google Scholar
• Cox JD, Stetz J, Pajak TF. Toxicity criteria of the radiation therapy oncology group (RTOG) and the european organization for research and treatment of cancer (EORTC). Int J Radiat Oncol Biol Phys. 1995;31(5):1341–1346. doi: 10.1016/0360-3016(95)00060-C.
   PubMed Web of Science ®Google Scholar
• Martinsson U, Svärd A-M, Taheri Kadkhoda Z, et al. Why are not all paediatric patients treated with protons? A complete national cohort from Sweden 2016–2019. Pediatr Blood Cancer. 2020;67:79.
   Web of Science ®Google Scholar
• Jung B, Montelius A, Dahlin H, et al. The conceptual design of a radiation oncology planning system. Comput Methods Programs Biomed. 1997;52(2):79–92. doi: 10.1016/s0169-2607(96)01783-x.
   PubMed Web of Science ®Google Scholar
• Grusell E, Montelius A, Russel KR, et al. Patient positioning for fractionated precision radiation treatment of targets in the head using fiducial markers. Radiother Oncol. 1994;33(1):68–72. doi: 10.1016/0167-8140(94)90088-4.
   PubMed Web of Science ®Google Scholar
• Pedroni E, Bacher H, Blattman T, et al. The 200-MeV proton therapy project at the Paul Scherrer institute: conceptual experimental tests of proton beam localization. Med Phys. 1995;22(1):37–53. doi: 10.1118/1.597522.
   PubMed Web of Science ®Google Scholar
• Karlsson M, Björk-Eriksson T, Mattsson O, et al. Distributed proton radiation therapy-a new concept for advanced competence support. Acta Oncol. 2006;45(8):1094–1101. doi: 10.1080/02841860600897876.
   PubMed Web of Science ®Google Scholar
• Ducatman BS, Scheithauer BW. Postirradiation neurofibrosarco-mas. Cancer. 1983;51(6):1028–1033. doi: 10.1002/1097-0142(19830315)51:6<1028::AID-CNCR2820510610>3.0.CO;2-3.
   PubMedGoogle Scholar
• Armstrong GT, Kawashima T, Leisenring W, et al. Aging and risk of severe, disabling, life-threatening, and fatal events in the childhood cancer survivor study. J Clin Oncol. 2014;32(12):1218–1227. doi: 10.1200/JCO.2013.51.1055.
   PubMed Web of Science ®Google Scholar
• Howell CR, Bjornard KL, Ness KK, et al. Cohort profile: the St. Jude lifetime cohort study (SJLIFE) for paediatric cancer survivors. Int J Epidemiol. 2021;50(1):39–49. doi: 10.1093/ije/dyaa203.
   PubMed Web of Science ®Google Scholar
• Gawade PL, Hudson MM, Kaste SC, et al. A systematic review of dental late effects in survivors of childhood cancer. Pediatr Blood Cancer. 2014;61(3):407–416. doi: 10.1002/pbc.24842.
   PubMed Web of Science ®Google Scholar
• Kosuda S, Satoh M, Yamamoto F, et al. Assessment of salivary gland dysfunction following chemoradiotherapy using quantitative salivary gland scintigraphy. Int J Radiat Oncol Biol Phys. 1999;45(2):379–384. doi: 10.1016/s0360-3016(99)00166-2.
   PubMed Web of Science ®Google Scholar
• Goldstein M, Maxymiw WG, Cummings BJ, et al. The effects of antitumor irradiation on mandibular opening and mobility: a prospective study of 58 patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999;88(3):365–373. doi: 10.1016/s1079-2104(99)70044-2.
   PubMed Web of Science ®Google Scholar
• Dörr W, Kallfel S, Herrmann T. Late bone and soft tissue sequelae of childhood radiotherapy relevance of treatment age and radiation dose in 146 children treated between 1970 and 1997. Strahlenther Onkol. 2013;189(7):529–534. doi: 10.1007/s00066-013-0361-y.
   PubMed Web of Science ®Google Scholar
• Fletcher BD. Effects of pediatric cancer therapy on the musculoskeletal system. Pediatr Radiol. 1997;27(8):623–636. doi: 10.1007/s002470050201.
   PubMed Web of Science ®Google Scholar
• Karsila-Tenovuo S, Jahnukainen K, Peltomaki T, et al. Disturbances in craniofacial morphology in children treated for solid tumors. Oral Oncol. 2001;37(7):586–592. doi: 10.1016/s1368-8375(01)00002-1.
   PubMed Web of Science ®Google Scholar
• Denys D, Kaste SC, Kun LE, et al. The effects of radiation on craniofacial skeletal growth: a quantitative study. Int J Pediatr Otorhinolaryngol. 1998;45(1):7–13. doi: 10.1016/s0165-5876(98)00028-7.
   PubMed Web of Science ®Google Scholar
• Fromm M, Littman P, Raney RB, et al. Late effects after treatment of twenty children with soft tissue sarcomas of the head and neck. Experience at a single institution with a review of the literature. Cancer. 1986;57(10):2070–2076. doi: 10.1002/1097-0142(19860515)57:10<2070::AID-CNCR2820571032>3.0.CO;2-G.
   PubMed Web of Science ®Google Scholar
• Sonis AL, Tarbell N, Valachovic RW, et al. Dentofacial development in long-term survivors of acute lymphoblastic leukemia. A comparison of three treatment modalities. Cancer. 1990;66(12):2645–2652. doi: 10.1002/1097-0142(19901215)66:12<2645::AID-CNCR2820661230>3.0.CO;2-S.
   PubMed Web of Science ®Google Scholar
• Guyuron B, Dagys AP, Munro IR, et al. Effect of irradiation on facial growth: a 7- to 25-year follow-up. Ann Plast Surg. 1983;11(5):423–427. doi: 10.1097/00000637-198311000-00010.
   PubMed Web of Science ®Google Scholar
• Pacheco R, Stock H. Effects of radiation on bone. Curr Osteoporos Rep. 2013;11(4):299–304. doi: 10.1007/s11914-013-0174-z.
   PubMed Web of Science ®Google Scholar
• Niewald M, Mang K, Barbie O, et al. Dental status, dental treatment procedures and radiotherapy as risk factors for infected osteoradionecrosis (IORN) in patients with oral cancer – a comparison of two 10 years’ observation periods. Springerplus. 2014;3:263. doi: 10.1186/2193-1801-3-263.
   PubMedGoogle Scholar
• Weinstein RS. Glucocorticoid-induced osteonecrosis. Endocrine. 2012;41(2):183–190. doi: 10.1007/s12020-011-9580-0.
   PubMed Web of Science ®Google Scholar
• Suryani IR, Ahmadzai I, Shujaat S, et al. Non-antiresorptive drugs associated with the development of medication-related osteonecrosis of the jaw: a systematic review and metaanalysis. Clin Oral Investig. 2022;26(3):2269–2279. doi: 10.1007/s00784-021-04331-7.
   PubMed Web of Science ®Google Scholar
• Söderström H, Brocki K, Lundin J, et al. Neurocognitive functions Before and After radiotherapy in pediatric brain tumor survivors. Pediatr Neurol. 2022;133:21–29. doi: 10.1016/j.pediatrneurol.2022.05.006.
   PubMed Web of Science ®Google Scholar
• Sklar CA, Antal Z, Chemaitilly W, et al. Hypothalamic-Pituitary and growth disorders in survivors of childhood cancer: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(8):2761–2784. doi: 10.1210/jc.2018-01175.
   PubMed Web of Science ®Google Scholar
• Suzuki J, Takaku A. Cerebrovascular ’moyamoyá disease: a disease showing abnormal net-like vessels in base of brain. Arch Neurol. 1969;20(3):288–299. doi: 10.1001/archneur.1969.00480090076012.
   PubMedGoogle Scholar
• Desai SS, Paulino AC, Mai WY, et al. Radiation-induced moyamoya syndrome. Int J Radiat Oncol Biol Phys. 2006;65(4):1222–1227. doi: 10.1016/j.ijrobp.2006.01.038.
   PubMed Web of Science ®Google Scholar
• Clemens E, van den Heuvel-Eibrink MM, Mulder RL, et al. Recommendations for ototoxicity surveillance for childhood, adolescent, and young adult cancer survivors: a report from the international late effects of childhood cancer guideline harmonization group in collaboration with the PanCare consortium. Lancet Oncol. 2019;20(1):e29–e41. doi: 10.1016/S1470-2045(18)30858-1.
   PubMed Web of Science ®Google Scholar
• Meyer AK, Young NM. Auditory late effects of chemotherapy. Cancer Treat Res. 2009;150:195–213.
   PubMedGoogle Scholar
• Nasman M, Bjork O, Soderhall S, et al. Disturbances in the oral cavity in pediatric long-term survivors after different forms of antineoplastic therapy. Pediatr Dent. 1994;16:217–223.
   PubMedGoogle Scholar
• Vissink A, Jansma J, Spijkervet FKL, et al. Oral sequelae of head and neck radiotherapy. Crit Rev Oral Biol Med. 2003;14(3):199–212. doi: 10.1177/154411130301400305.
   PubMedGoogle Scholar
• Effinger KE, Migliorati CA, Hudson MM, et al. Oral and dental late effects in survivors of childhood cancer: a children’s oncology group report. Support Care Cancer. 2014;22(7):2009–2019. doi: 10.1007/s00520-014-2260-x.
   PubMed Web of Science ®Google Scholar
• Gawade PL, Hudson MM, Kaste SC, et al. Systematic review of selected musculoskeletal late effects in survivors of childhood cancer. Curr Pediatr Rev. 2014;10(4):249–262. doi: 10.2174/1573400510666141114223827.
   PubMedGoogle Scholar
• Paulino AC, Wen BC, Brown CK, et al. Late effects in children treated with radiation therapy for Wilms’ tumor. Int J Radiat Oncol Biol Phys. 2000;46(5):1239–1246. doi: 10.1016/s0360-3016(99)00534-9.
   PubMed Web of Science ®Google Scholar
• van Dijk IW, Oldenburger F, Cardous-Ubbink MC, et al. Evaluation of late adverse events in longterm Wilms’ tumor survivors. Int J Radiat Oncol Biol Phys. 2010;78(2):370–378. doi: 10.1016/j.ijrobp.2009.08.016.
   PubMed Web of Science ®Google Scholar
• Bright CJ, Reulen RC, Winter DL, et al. Risks of subsequent primary neoplasms in survivors of adolescents and young adult cancer (teenage and young adult cancer survivor study): a population-based, cohort study. Lancet Oncol. 2019;20(4):531–545. doi: 10.1016/S1470-2045(18)30903-3.
   PubMed Web of Science ®Google Scholar
• Palmer, Tsang Tinkle. Late effects of radiation therapy in paediatric patients and survivorship. Pediatr Blood Cancer. 2021;68(suppl 2):e28349.
   PubMedGoogle Scholar
• Leiser D, Calaminus G, Malyapa R, et al. Tumour control and quality of life in children with rhabdomyosarcoma treated with pencil beam scanning proton therapy. Radiother Oncol. 2016;120(1):163–168. doi: 10.1016/j.radonc.2016.05.013.
   PubMed Web of Science ®Google Scholar
• Yock TI, Yeap BY, Ebb DH, et al. Long-term toxic effects of proton radiotherapy for paediatric medulloblastoma: a phase 2 single-arm study. Lancet Oncol. 2016;17(3):287–298. doi: 10.1016/S1470-2045(15)00167-9.
   PubMed Web of Science ®Google Scholar
• Ishida Y, Sakamoto N, Kamibeppu K, et al. Late effects and quality of life of childhood cancer survivors: part 2. Impact of radiotherapy. Int J Hematol. 2010;92(1):95–104. doi: 10.1007/s12185-010-0611-z.
   PubMed Web of Science ®Google Scholar
• Martinsson U, Kristensen I, Swärd A-M. Grade 3 and 4 late side effects after radiotherapy – data from the Swedish RADTOX registry. Edinburgh: ESLCCC (European Symposium on Late Complications after Childhood Cancer); 2014.
   Google Scholar